|
López-Cuenca A, Marín F, Roldán V, González-Conejero R, Hernández-Romero D, Valdés M, Lip GY. Genetic polymorphisms and atrial fibrillation: Insights into the prothrombotic state and thromboembolic risk. Ann Med. 2010 Dec;42(8):562-75. doi: 10.3109/07853890.2010.507601. Epub 2010 Aug 4. Review. PubMed PMID: 20681943.
AÑO: 2010; IF: 4.323
|
20681943
|
Corral J, Antón AI, Quiroga T, González-Conejero R, Pereira J, Roldán V, Vicente V, Mezzano D. Influence of the F12 -4 C>T polymorphism on hemostatic tests. Blood Coagul Fibrinolysis. 2010 Oct;21(7):632-9. doi: 10.1097/MBC.0b013e32833a9048. PubMed PMID: 20814302.
AÑO: 2010; IF: 1.408
|
|
Lip GY, Durrani OM, Roldan V, Lip PL, Marin F, Reuser TQ. Peri-operative management of ophthalmic patients taking antithrombotic therapy. Int J Clin Pract. 2011 Mar;65(3):361-71. doi: 10.1111/j.1742-1241.2010.02538.x. Review. PubMed PMID: 21314873.
AÑO: 2011; IF: 2.415
|
|
Roldán V, Marín F, Muiña B, Torregrosa JM, Hernández-Romero D, Valdés M, Vicente V, Lip GY. Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients. J Am Coll Cardiol. 2011 Jun 21;57(25):2496-504. doi: 10.1016/j.jacc.2010.12.033. Epub 2011 Apr 14. PubMed PMID: 21497043.
AÑO: 2011; IF: 14.156
|
|
Marín F, Roldán V, Martínez JG, Hernández-Madrid A, Hernández-Romero D, Ortego M, Ibáñez A, Marín-Marín I, Navarro X, Lip GY, Moro C. Influence of cardiac resynchronization therapy on indices of inflammation, the prothrombotic state and tissue remodeling in systolic heart failure: a pilot study. Thromb Res. 2011 Oct;128(4):391-4. doi: 10.1016/j.thromres.2011.05.022. Epub 2011 Jun 26. PubMed PMID: 21708399.
AÑO: 2011; IF: 2.44
|